Advertisement

Bupivacaine Injection

[24 May 2016]

Products Affected - Description

Marcaine solution for injection, Hospira
0.25%, 50 mL multiple dose vial, 1 count (NDC 00409-1587-50)
0.5%, 10 mL preservative-free vial, 10 count (NDC 00409-1560-10)
0.5%, 50 mL multiple dose vial, 1 count (NDC 00409-1610-50)
 
Sensorcaine-MPF solution for injection, Fresenius Kabi
0.75%, 30 mL preservative-free vial, 25 count (NDC 63323-0472-37)
 
Bupivacaine solution for injection, AuroMedics
0.25%, 30 mL preservative-free vial, 25 count (NDC 55150-0168-30)
0.5%, 30 mL preservative-free vial, 25 count (NDC 55150-0170-30)
0.75%, 10 mL preservative-free vial, 25 count (NDC 55150-0171-10)
0.75%, 30 mL preservative-free vial, 25 count (NDC 55150-0172-30)
 
Bupivacaine solution for injection, Hospira
0.25%, 10 mL preservative-free vial, 25 count (NDC 00409-1159-01)
0.25%, 20 mL glass ampule, sterile pack, 5 count (NDC 00409-4272-01)
0.25%, 30 mL glass ampule, 25 count (NDC 00409-1158-01)
0.25%, 30 mL preservative-free vial, 25 count (NDC 00409-1159-02)
0.5%, 10 mL preservative-free vial, 25 count (NDC 00409-1162-01)
0.5%, 20 mL glass ampule, sterile pack, 5 count (NDC 00409-4273-01)
0.5%, 30 mL glass ampule, 25 count (NDC 00409-1161-01)
0.5%, 50 mL multiple dose vial, 25 count (NDC 00409-1163-01)
0.75%, 10 mL preservative-free vial, 25 count (NDC 00409-1165-01)

Reason for the Shortage

  • AuroMedics has not provided a reason for the shortage.
  • Fresenius Kabi has Sensorcaine on shortage due to increased demand for the product.
  • Hospira has bupivacaine on shortage due to manufacturing delays.

Available Products

Marcaine solution for injection, Hospira
0.25%, 10 mL preservative-free vial, 10 count (NDC 00409-1559-10)
0.25%, 30 mL preservative-free vial, 10 count (NDC 00409-1559-30)
0.5%, 30 mL preservative-free vial, 10 count (NDC 00409-1560-29)
0.75%, 10 mL preservative-free vial, 10 count (NDC 00409-1582-10)
0.75%, 30 mL preservative-free vial, 10 count (NDC 00409-1582-29)

Sensorcaine solution for injection, Fresenius Kabi
0.25%, 50 mL multiple dose vial, 25 count (NDC 63323-0465-57)
0.5%, 50 mL multiple dose vial, 25 count (NDC 63323-0467-57)

Sensorcaine-MPF solution for injection, Fresenius Kabi
0.25%, 10 mL preservative-free vial, 25 count (NDC 63323-0464-17)
0.25%, 30 mL preservative-free vial, sterile pack, 25 count (NDC 63323-0464-31)
0.25%, 30 mL preservative-free vial, 25 count (NDC 63323-0464-37)
0.5%, 10 mL preservative-free vial, 25 count (NDC 63323-0466-17)
0.5%, 30 mL preservative-free vial, 25 count (NDC 63323-0466-37)
0.5%, 30 mL preservative-free vial, sterile pack, 25 count (NDC 63323-0466-31)
0.75%, 10 mL preservative-free vial, 25 count (NDC 63323-0472-17)
 
Bupivacaine solution for injection, AuroMedics
0.25%, 10 mL preservative-free vial, 25 count (NDC 55150-0167-10)
0.5%, 10 mL preservative-free vial, 25 count (NDC 55150-0169-10)
 
Bupivacaine solution for injection, Hospira
0.25%, 50 mL multiple dose vial, 25 count (NDC 00409-1160-01)
0.5%, 30 mL preservative-free vial, 25 count (NDC 00409-1162-02)
0.75%, 30 mL preservative-free vial, 25 count (NDC 00409-1165-02)

Estimated Resupply Dates

  • AuroMedics has 0.25% bupivacaine 30 mL vials, 0.5% bupivacaine 30 mL vials, and 0.75% bupivacaine 10 mL and 30 mL vials on intermittent back order and the company is releasing product as it becomes available.
  • Hospira has 0.25% bupivacaine 30 mL ampules and 20 mL ampule sterile packs and 0.5% bupivacaine 20 mL ampule sterile packs on back order and the company cannot estimate a release date. The 0.25% bupivacaine 10 mL preservative-free vials are on back order and the company estimates a release date of mid-June 2016. The 0.25% bupivacaine 30 mL preservative-free vials, 0.5% bupivacaine 10 mL preservative-free vials, and 0.5% bupivacaine 30 mL ampules are available in limited supply. The 0.75% bupivacaine 10 mL preservative-free vials are on back order and the company estimates a release date of early-July 2016.
  • Hospira has 0.25% Marcaine 50 mL multiple dose vials on back order and the company estimates a release date in mid-June 2016. The 0.5% Marcaine 10 mL preservative free vials and 50 mL vials are on back order and the company estimates a release date of late-May 2016.
  • Fresenius Kabi has 0.75% Sensorcaine-MPF 30 mL preservative-free vials on back order and the company estimates a release date of early-June 2016.

Related Shortages

Updated

May 24 and 10, April 29 and 25, March 11 and 4, January 12, 2016; December 22 and 10, November 4, September 25 and 16, July 17 and 2, June 1, April 29, 16 and 9, March 23, February 26, 24 and 3, 2015; December 19, 16 and 2, November 21 and 6, October 24 and 14, September 19 and 3, August 8, July 16 and 3, June 26, 19 and 2, May 21, April 25 and 7, March 17, February 27, 21 and 7, January 6, 2014; December 3, November 11 and 7, October 30 and 9, September 5, August 6, July 12, June 13, May 24, 17 and 10, April 4, March 13 and 5, February 17 and 7, January 17, 2013; December 12, November 9, October 22, September 19, August 22 and 9, July 10, June 18, May 17, April 16, March 27 and 7, February 22 and 8, January 25 and 5, 2012; December 21 and 7, November 21 and 16, 2011, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing